about
sameAs
A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease riskGenetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisIdentification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammationInnate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatmentCCL8/MCP-2 association analysis in patients with Alzheimer's disease and frontotemporal lobar degenerationSORL1 Gene is Associated with the Conversion from Mild Cognitive Impairment to Alzheimer's DiseaseCommon variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's diseaseGenome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's diseaseA study of the association between the ADAM12 and SH3PXD2A (SH3MD1) genes and Alzheimer's disease.A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia.Novel missense progranulin gene mutation associated with the semantic variant of primary progressive aphasia.The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study.Non-progressive leukoencephalopathy with bilateral anterior temporal cysts: a case report and review of the literature.Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia.Chemokine network in multiple sclerosis: role in pathogenesis and targeting for future treatments.E-selectin A561C and G98T polymorphisms influence susceptibility and course of multiple sclerosis.Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease.Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration.Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.CXCL10 haplotypes and multiple sclerosis: association and correlation with clinical course.Association of a NOS1 promoter repeat with Alzheimer's disease.Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis.Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration.MDC/CCL22 intrathecal levels in patients with multiple sclerosis.MCP-1 A-2518G polymorphism: effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels.GRN variability contributes to sporadic frontotemporal lobar degeneration.Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population.Treatment of Alzheimer's disease: symptomatic and disease-modifying approaches.White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort.HLA-class I markers and multiple sclerosis susceptibility in the Italian populationCognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study.Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease.Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.Consensus guidelines for lumbar puncture in patients with neurological diseases.GSK3β genetic variability in patients with Multiple Sclerosis.Progress in Alzheimer's disease.Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes.Frontotemporal dementia and its subtypes: a genome-wide association study.Failure to replicate an association of rs5984894 SNP in the PCDH11X gene in a collection of 1,222 Alzheimer's disease affected patients.A functional variant in ERAP1 predisposes to multiple sclerosis.
P50
Q24336362-F3B2D6FA-31DB-441B-B4A8-798B1D8A3A53Q24635370-FF615F2B-775C-48B2-8FB8-DBCCFEDF3182Q24644706-3CB4EB45-CE62-42E5-BF77-207F4E70A73FQ26825570-C2A81569-9759-4C36-B120-39A48471261FQ28243714-E63D27FB-A10E-4682-A9E7-E616B6774615Q28260619-3991AF78-79F6-44BB-BA8B-212FB745629CQ29614879-75967E91-380F-42CB-8072-DB5CA84770A4Q29614881-2B0A7881-6303-4D3B-90D0-45D1171B78B4Q30157086-1A1EFFE7-DB81-4638-B1BA-82D9C6F4B040Q30402493-E0773947-8323-421A-9810-44AC3BCE728CQ30429851-6C56F36F-621A-422E-9054-2532E752447FQ30433658-c9cbea44-412b-a37b-7278-44359ee26020Q30979529-EDABED6B-693D-4C36-B8FC-BACB322AD010Q31055209-70A83BE6-6045-4D85-8B5A-99D7BF9C207FQ33214417-4A5DE1B9-9C46-42B4-8044-E7BA19452A56Q33217929-8F50F0A5-B0C3-48EE-991C-2B308A67EFE7Q33227799-D318E510-AC47-4A4D-B022-E9EA2C4B2608Q33231194-3B2E348B-01ED-4056-B3D6-8E3E04D66D6BQ33239536-83D45075-DDB8-474E-A058-1B7B5436B115Q33270221-FB6425BD-F189-4F1C-BD8B-FF08EBD8947DQ33281529-D2DC68D6-F768-46AD-A04A-FD3D07EA25D5Q33304257-60BB7AA1-BBBB-424B-AB0A-280AF568D800Q33315398-F0C95280-D777-4CB4-B372-C4326CAB27FAQ33315609-EDCA9B68-09F6-482C-9EA8-8677743381A3Q33459734-3C73F18B-2B01-46B2-BFA8-5D198B3DCF64Q33522914-6A87D92E-E817-477C-823C-F26C3A826F0FQ33533349-6AAB8722-3763-41C1-A65B-BD5C973E0F76Q33542762-1793085D-EEDE-4BF5-8E8F-00FB013D3228Q33676267-D3A718A4-C35A-421F-B9F7-0B0B74A21E2BQ33710384-B636EA30-06A8-409E-93D2-4C27CCE08708Q33729886-ACD61766-3B0A-467B-8879-73436CC20F88Q33742148-77B55211-AB09-435D-AA76-E3AF9ED67D4AQ33747916-A0C2A8FD-92A7-4306-9F4A-2F87714A4BA6Q33753332-AF2EBA92-98AF-4B3D-B5B7-FA4F0392F0ECQ33884258-20BD6086-C7B0-4B02-8F54-0E45231676DDQ33943357-B9B61959-511A-42B1-A15E-0267A9FE7664Q33946311-5180448E-B54C-43FA-932D-5936A022B631Q33955007-5D2A5C2B-8C46-4465-BB74-FB9C78FE581FQ34121245-817D75E2-0751-4387-B021-227CF1C0B4A9Q34130800-657C0757-9D82-4D09-8EEF-17D5035E18A8
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Daniela Galimberti
@ast
Daniela Galimberti
@en
Daniela Galimberti
@es
Daniela Galimberti
@nl
Daniela Galimberti
@sl
type
label
Daniela Galimberti
@ast
Daniela Galimberti
@en
Daniela Galimberti
@es
Daniela Galimberti
@nl
Daniela Galimberti
@sl
prefLabel
Daniela Galimberti
@ast
Daniela Galimberti
@en
Daniela Galimberti
@es
Daniela Galimberti
@nl
Daniela Galimberti
@sl
P214
P244
P1053
K-6542-2016
P106
P1153
6701617660
P21
P213
0000 0000 4837 3413
P214
P244
n2008182817
P2798
P31
P3829
P396
IT\ICCU\MILV\213599
P496
0000-0002-9284-5953
P569
1970-01-01T00:00:00Z
P734
P735
P7859
lccn-n2008182817